Preclinical pharmacokinetics and biodistribution studies of 89Zr-labeled pembrolizumab for human dosimetry estimation

被引:0
|
作者
Ehlerding, Emily [1 ]
England, Christopher [1 ]
Hernandez, Reinier [1 ]
Graves, Stephen [2 ]
Barnhart, Todd [1 ]
Cai, Weibo [1 ]
机构
[1] Univ Wisconsin, Madison, WI USA
[2] Univ Wisconsin, Dept Med Phys, 1530 Med Sci Ctr, Madison, WI 53706 USA
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
1023
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Preclinical Pharmacokinetics and Biodistribution Studies of 89Zr-Labeled Pembrolizumab
    England, Christopher G.
    Ehlerding, Emily B.
    Hernandez, Reinier
    Rekoske, Brian T.
    Graves, Stephen A.
    Sun, Haiyan
    Liu, Glenn
    Mcneel, Douglas G.
    Barnhart, Todd E.
    Cai, Weibo
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (01) : 162 - 168
  • [2] Biodistribution studies of 89Zr-labeled nanodiamonds in mice using PET and MRI
    Eberhardt, Nina
    Loeffler, Jessica
    Raabe, Marco
    Li, Hao
    Abaei, Alireza
    Herrmann, Hendrik
    Solbach, Christoph
    Weil, Tanja
    Beer, Ambros
    Rasche, Volker
    Winter, Gordon
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [3] Dosimetry Assessment of Injected 89Zr-Labeled Monoclonal Antibodies in Humans
    Zakaly, Hesham Mahmoud Harned
    Mostafa, Mostafa Yuness Abdelfatah
    Zhukovsky, Michael
    RADIATION RESEARCH, 2019, 191 (05) : 466 - 474
  • [4] Tumor Uptake and Biodistribution of 89Zr-Labeled Pembrolizumab in Patients with Metastatic Non-Small-Cell Lung Cancer
    Niemeijer, A.
    Oprea-Lager, D.
    Huisman, M.
    Boellaard, R.
    Hoekstra, O.
    De Wit-Van Der Veen, L.
    Bahce, I.
    Vugts, D.
    Van Dongen, G.
    Thunnissen, E.
    Smit, E.
    De Langen, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S443 - S443
  • [5] Preclinical tumor imaging with 89Zr-labeled monoclonal antibody ramucirumab
    Novy, Z.
    Janousek, J.
    Barta, P.
    Petrik, M.
    Hajduch, M.
    Trejtnar, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S647 - S647
  • [6] A preclinical evaluation of 89Zr-labeled PSMA ligands for pre-treatment dosimetry for 177Lu-labeled PSMA therapy
    Prive, B.
    Derks, Y. H. W.
    Franssen, G. M.
    Peters, S. M. B.
    Konijnenberg, M. W.
    Gotthardt, M.
    Janssen, M. J. R.
    Laverman, P.
    Nagarajah, J.
    Heskamp, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S374 - S375
  • [7] Comparative analyses of the biodistribution of 89Zr-labeled human serum albumin in the mouse and HET-CAM model
    Hilbrig, Colmar
    Loeffler, Jessica
    Fischer, Gabriel
    Herrmann, Hendrik
    Solbach, Christoph
    Huber-Lang, Markus
    Rasche, Volker
    Beer, Ambros
    Winter, Gordon
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63
  • [8] Comparative studies of 89Zr-labeled human serum albumin in the mouse and CAM model
    Hilbrig, C.
    Loeffler, J.
    Herrmann, H.
    Solbach, C.
    Huber-Lang, M.
    Rasche, V.
    Beer, A.
    Winter, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S445 - S445
  • [9] Evaluation of whole-body biodistribution of 89Zr-labeled antibodies in cynomolgus macaque with PET
    Sasaki, T.
    Kimura, S.
    Noda, A.
    Murakami, Y.
    Takenaka, F.
    Miyoshi, S.
    Matsuura, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S230 - S230
  • [10] 89Zr-Labeled liposomes as theranostic agents
    Perez-Medina, Carlos
    Abdel-Atti, Dalya
    Zhang, Yachao
    Irwin, Christopher
    Binderup, Tina
    Fayad, Zahi
    Lewis, Jason
    Mulder, Willem
    Reiner, Thomas
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55